More articles from Radiopharmaceutical Sciences (RPSC) YIA Symposium

You have access
Delta-like Ligand 3 (DLL3) is a novel target for molecular imaging of Neuroendocrine Prostate Cancer
Joshua Korsen, Teja Kalidindi, Samantha Khitrov, Hassan Khuram, John Piorier, Charles Rudin, Yu Chen, Naga Vara Kishore Pillarsetty and Jason Lewis

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 133;
You have access
Copper(I)-mediated ¹¹C-carboxylation of (hetero)arylstannanes: radiosynthesis of [¹¹C]bexarotene.
Ian Duffy, Kenneth Dahl and Neil Vasdev

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 137;
You have access
Direct Aromatic ¹⁸F-labeling of Tetrazines: A Rapid and Convenient Entry to Tetrazines for Pretargeted PET Imaging
Rocio Garcia Vazquez, Umberto Maria Battisti, Daniel Lloyd Stares, Ida Nymann Petersen, Francois Crestey, Dennis Svatunek, Hannes Mikula, Jesper L. Kristensen, Andreas Kjaer and Matthias Herth

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 134;
You have access
Pretargeted Theranostic Radioimmunotherapy with a Cu-64/Cu-67 Isotopologue Pair
Outi Keinaenen, Kimberly Fung, James Brennan, Nicholas Zia, Matthew Harris, Ellen Van Dam, Colin Biggin, Amos Hedt, Jon Stoner, Paul Donnelly, Jason Lewis and Brian Zeglis

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 132;
You have access
Simple synthesis and use of [¹¹C]carbonyl difluoride for the intracyclic labelingof heterocycles
Erik Jakobsson, Shuiyu Lu, Sanjay Telu and Victor Pike

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 136;
You have access
Translation of [¹⁸F]SiFAlin-TATE to the clinic: Radiosynthesis, biodistribution and first clinical results
Simon Lindner, Peter Bartenstein, Klaus Jurkschat, Carmen Wangler, Bjorn Wangler, Ralf Schirrmacher and Harun Ilhan

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 131;
You have access
18F-FDG PET/CT of extramedullary disease in newly diagnosed multiple myeloma: imaging findings and its correlation with clinical indicators and outcome
Yunyun Zhao and Qian Wang

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 135;
You have access
CXCR4 and ACKR3 binding azamacrocyclic compounds for targeted PET imaging and therapeutic applications in cancer.
Isaline Renard, Kate Nicholson, Thomas D'Huys, Benjamin Burke, Juozas Domarkas, Timothy Hubin, Dominique Schols, Christopher Cawthorne and Steve Archibald

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 133;
You have access
Biodistribution Studies of Chelated Ce-134/La-134 as Positron-Emitting Analogues of Alpha-Emitting Therapy Radionuclides
Tyler Bailey, Andrew Lakes, Dahlia An, Stacey Gauny and Rebecca Abergel

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 130;
You have access
Induction and repair of DNA double-strand breaks in blood leukocytes of prostate cancer patients during Lu-177-PSMA therapy
Sarah Schumann, Harry Scherthan, Constantin Lapa, Sebastian Serfling, Razan Muhtadi, Michael Lassmann and Uta Eberlein

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 128;

Main menu

User menu

Search

More articles from Radiopharmaceutical Sciences (RPSC) YIA Symposium

Pages